2023 - 2024 LEGISLATURE
LRB-4153/1
JKS:klm
2023 SENATE JOINT RESOLUTION 69
September 12, 2023 - Introduced by Senators ROYS, BALLWEG, CABRAL-GUEVARA,
CARPENTER, HESSELBEIN, L. JOHNSON, LARSON, PFAFF, SPREITZER, TAYLOR and
WIRCH, cosponsored by Representatives SUBECK, ROZAR, C. ANDERSON, J.
ANDERSON, ANDRACA, BARE, BINSFELD, CABRERA, CLANCY, CONLEY, CONSIDINE,
DITTRICH, DRAKE, EMERSON, HAYWOOD, JACOBSON, JOERS, S. JOHNSON, MADISON,
MAGNAFICI, MELOTIK, MOORE OMOKUNDE, MURPHY, MURSAU, O'CONNOR,
OHNSTAD, ORTIZ-VELEZ, PALMERI, RATCLIFF, SHANKLAND, SINICKI, SNODGRASS,
STUBBS, VINING and KITCHENS. Referred to Committee on Senate
Organization.
1 Relating to: designating September 2023 and September 2024 as Ovarian Cancer
2 Awareness Month.
3 Whereas, ovarian cancer is the deadliest of all gynecologic cancers and is most
4 common in postmenopausal women; and
5 Whereas, ovarian cancer ranks 17th in rates of new cancer cases among women
6 in the United States, but ranks sixth among cancer deaths for women, and is the
7 leading cause of death from cancer of the female reproductive system; and
8 Whereas, ovarian cancer accounts for 2.1 percent of all new cancer cases for
9 women, but 4.6 percent of all cancer deaths among women; and
10 Whereas, every woman is at risk for ovarian cancer regardless of age, heritage,
11 or medical history, and women with a family history of ovarian cancer and other
12 genetic factors are at an even higher risk; and
13 Whereas, approximately 230,000 women in the United States are living with
14 ovarian cancer; and
 LRB-4153/1
2023 - 2024 Legislature -2- JKS:klm
1 Whereas, the incidence of ovarian cancer in Wisconsin is slightly higher than
2 the national average; and
3 Whereas, only half of women diagnosed with ovarian cancer survive beyond five
4 years; and
5 Whereas, ovarian cancer may not cause early symptoms, and therefore its
6 diagnosis often does not occur until the disease has reached an advanced stage, at
7 which point the cancer may spread to other parts of the body; and
8 Whereas, the five-year survival rate for Stage 1 ovarian cancer is more than
9 90 percent, but the five year-survival rate for late-stage ovarian cancer is below 30
10 percent, and only 17 percent of ovarian cancers are diagnosed at Stage 1; and
11 Whereas, while a mammogram can detect breast cancer and a pap smear can
12 detect cervical cancer, there is no reliable early detection test for ovarian cancer; and
13 Whereas, additional ovarian cancer research and clinical trials are urgently
14 needed to develop prevention strategies, early detection tools, and better therapies,
15 in hopes of eventually finding a cure; and
16 Whereas, awareness and education are crucial, and women's lives will be saved
17 through public awareness about ovarian cancer and its risk factors, signs, and
18 symptoms; now, therefore, be it
19 Resolved by the senate, the assembly concurring, That the legislature
20 proclaims September 2023 and September 2024 to be Ovarian Cancer Awareness
21 Month in Wisconsin.
22 (END)